Thrivent Financial for Lutherans’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-11,009
| Closed | -$1.38M | – | 2530 |
|
|
2021
Q2 | $1.38M | Hold |
11,009
| – | – | ﹤0.01% | 1648 |
|
|
2021
Q1 | $1.49M | Sell |
11,009
-1,633
| -13% | -$221K | ﹤0.01% | 1598 |
|
|
2020
Q4 | $1.62M | Hold |
12,642
| – | – | ﹤0.01% | 1451 |
|
|
2020
Q3 | $1.42M | Sell |
12,642
-9
| -0.1% | -$1.01K | ﹤0.01% | 1362 |
|
|
2020
Q2 | $1.21M | Hold |
12,651
| – | – | ﹤0.01% | 1373 |
|
|
2020
Q1 | $1.14M | Buy |
+12,651
| New | +$1.14M | ﹤0.01% | 1225 |
|
|
2018
Q3 | – | Sell |
-28,578
| Closed | -$1.39M | – | 2038 |
|
|
2018
Q2 | $1.39M | Buy |
+28,578
| New | +$1.39M | ﹤0.01% | 1060 |
|
|
2017
Q2 | – | Sell |
-26,920
| Closed | -$713K | – | 2093 |
|
|
2017
Q1 | $713K | Buy |
26,920
+9,440
| +54% | +$250K | ﹤0.01% | 1354 |
|
|
2016
Q4 | $446K | Hold |
17,480
| – | – | ﹤0.01% | 1559 |
|
|
2016
Q3 | $633K | Buy |
+17,480
| New | +$633K | ﹤0.01% | 1348 |
|
|
2016
Q1 | – | Sell |
-37,630
| Closed | -$1.84M | – | 2040 |
|
|
2015
Q4 | $1.84M | Buy |
37,630
+7,210
| +24% | +$352K | 0.01% | 877 |
|
|
2015
Q3 | $757K | Sell |
30,420
-6,850
| -18% | -$170K | ﹤0.01% | 1044 |
|
|
2015
Q2 | $1.18M | Hold |
37,270
| – | – | 0.01% | 780 |
|
|
2015
Q1 | $1.42M | Sell |
37,270
-30
| -0.1% | -$1.14K | 0.01% | 764 |
|
|
2014
Q4 | $1.45M | Sell |
37,300
-3,000
| -7% | -$117K | 0.01% | 763 |
|
|
2014
Q3 | $1.22M | Buy |
+40,300
| New | +$1.22M | 0.01% | 817 |
|